Clinical and microbiological aspects of Trichomonas vaginalis

Clinical Microbiology Reviews

Volumn 11, Issue 2, 1998, Pages 300-317

  Petrin, Dino ^a   Delgaty, Kiera ^a   Bhatt, Renuka ^a   Garber, Gary ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CLOTRIMAZOLE; CYSTEINE PROTEINASE; FLUNIDAZOLE; METRONIDAZOLE; NIMORAZOLE; NITROIMIDAZOLE DERIVATIVE; ORNIDAZOLE; SECNIDAZOLE; TINIDAZOLE; TRICHOMONAS VACCINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; CLINICAL PROTOCOL; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG SYNTHESIS; HEMOLYSIS; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INCIDENCE; INFECTION CONTROL; INTRAVAGINAL DRUG ADMINISTRATION; NEWBORN DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; STANDARDIZATION; SYMPTOM; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINARY TRACT INFECTION; VAGINA FLORA;

ANIMALIA; BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 0031978286     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.2.300     Document Type: Review

References (316)

1. Abonyi, A. 1992. In vivo observations of the division of the oversized round forms of Trichomonas vaginalis in culture. Angew. Parasitol. 33:65-68. (In German.)
2. Abonyi, A. 1995. Examination of nonflagellate and flagellate round forms of Trichomonas vaginalis by transmission electron microscopy. Appl. Parasitol. 36:303-310.
3. Abraham, M. C., M. Desjardins, L. G. Filion, and G. E. Garber. 1996. Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection. Infect. Immun. 64:3571-3575.
4. Ackers, J. P. 1990. Immunologic aspects of human trichomoniasis. p. 36-52. In B. M. Honigberg (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
5. Ahmed-Jushuf, I., A. E. Murray, and J. McKeown. 1988. Managing trichomonal vaginitis refractory to conventional treatment with metronidazole. Genitourin. Med. 64:25-29.
6. Alderete, J. F. 1987. Trichomonas vaginalis NYH286 phenotypic variation may be coordinated for a repertoire of trichomonad surface immunogens. Infect. Immun. 55:1957-1962.
7. Alderete, J. F. 1988. Does lactobacillus vaccine for trichomoniasis, Solco Trichovac, induce antibody reactive with Trichomonas vaginalis? Genitourin. Med. 64:118-123.
8. Alderete. J. F. 1988. Alternating phenotypic expression of two classes of Trichomonas vaginalis surface markers. Rev. Infect. Dis. 10(Suppl. 2):S408-S412.
9. Alderete, J. F., R. Arroyo, D. C. Dailey, J. Engbring, M. A. Khoshnan, and M. W. Lehker. 1992. Molecular analysis of Trichomonas vaginalis surface protein repertoires. Mol. Cell Biol. Hum. Dis. Ser. 1:173-202.
10. Alderete, J. F., R. Arroyo, and M. W. Lehker. 1994. Identification of fibronectin as a receptor for bacterial cytoadherence. Methods Enzymol. 236:318-333.
11. Alderete, J. F., P. Demes, A. Gombosova, M. Valent, A. Yanoska, H. Fabusova, G. E. Garza, and E. C. Metcalfe. 1987. Phenotypes and protein-epitope phenotypic variation among fresh isolates of Trichomonas vaginalis. Infect. Immun. 55:1037-1041.
12. Alderete, J. F., and G. E. Garza. 1984. Soluble Trichomonas vaginalis antigens in cell-free culture supernatants. Mol. Biochem. Parasitol. 13:147-158.
13. Alderete, J. F., and G. E. Garza. 1985. Specific nature of Trichomonas vaginalis parasitism of host cell surfaces. Infect. Immun. 50:701-708.
14. Alderete, J. F., and G. E. Garza. 1988. Identification and properties of Trichomonas vaginalis proteins involved in cytadherence. Infect. Immun. 56:28-33.
15. Alderete, J. F., and L. Kasmala. 1986. Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis. Infect. Immun. 53:697-699.
16. Alderete, J. F., L. Kasmala, E. Metcalfe, and G. E. Garza. 1986. Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants. Infect. Immun. 53:285-293.
17. Alderete, J. F., E. Newton, C. Dennis, J. Engbring, and K. A. Neale. 1991. Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis. Genitourin. Med. 67:220-225.
18. Alderete, J. F., J. L. O'Brien, R. Arroyo, J. A. Engbring, O. Musatovova, O. Lopez, C. Lauriano, and J. Nguyen. 1995. Cloning and molecular characterization of two genes encoding adhesion proteins involved in Trichomonas vaginalis cytoadherence. Mol. Microbiol. 17:69-83.
19. Alderete, J. F., and E. Pearlman. 1984. Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers. Br. J. Vener. Dis. 60:99-105.
20. Alderete, J. F., D. Provenzano, and W. Lehker. 1995. Iron mediates Trichomonas vaginalis resistance to complement lysis. Microb. Pathog. 19:93-103.
21. al-Salihi, F. L., J. P. Curran, and J. Wang. 1974. Neonatal Trichomonas vaginalis: report of three cases and review of the literature. Pediatrics 53:196-200.
22. Arese, P., and P. Cappuccinelli. 1974. Glycolysis and the pentose phosphate cycle in Trichomonas vaginalis. I. Enzyme activity pattern and the constant proportion quintet. Int. J. Biochem. 5:859-865.
23. Arroyo, R., and J. F. Alderete. 1989. Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells. Infect. Immun. 57:2991-2997.
24. Arroyo, R., J. Engbring, and J. F. Alderete. 1992. Molecular basis of host epithelial cell recognition by Trichomonas vaginalis. Mol. Microbiol. 6:853-862.
25. Arroyo, R., A. Gonzalez-Robles, A. Martinez-Palomo, and J. F. Alderete. 1993. Signalling of Trichomonas vaginalis for amoeboid transformation and adhesion synthesis follows cytoadherence. Mol. Microbiol. 7:299-309.
26. Attardi, G., and G. Schatz. 1988. Biogenesis of mitochondria. Annu. Rev. Cell Biol. 4:289-333.
27. Baerenstein, H. D. 1961. Lactic dehydrogenase in Trichomonas vaginalis. J. Parasitol. 47:279-284.
28. Barch, T. A., C. W. Rees, and L. V. Reardon. 1959. Epidemiological studies on human trichomoniasis. Am. J. Trop. Med. Hyg. 8:312-318.
29. Beach, D. H., G. G. Holz, Jr., B. N. Singh, and D. G. Lindmark. 1990. Fatty acid and sterol metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 38:175-190.
30. Beach, D. H., G. G. Holz, Jr., B. N. Singh, and D. G. Lindmark. 1991. Phospholipid metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 44:97-108.
31. Beal, C., R. Goldsmith, M. Kotby, M. Sherif, A. el-Tagi, A. Farid, S. Zakaria, and J. Eapen. 1992. The plastic envelope method, a simplified technique for culture diagnosis of trichomoniasis. J. Clin. Microbiol. 30:2265-2268. (Erratum, 31:174, 1993.)
32. Beard, C. M., K. L. Noller, W. M. O'Fallon, L, T. Kurland, and M. B. Dockerty. 1979. Lack of evidence for cancer due to use of metronidazole. N. Engl. J. Med. 301:519-522.
33. Bednova, V. N., L. A. Bakalova, A. V. Bugrov, T. I. Navolotskaia, V. I. Kisina, and T. E. Vakhinina. 1992. Ofloxacin and ciproxacin in the treatment of sexually transmitted diseases. Antibiot. Khimioter. 37:42-44. (In Russian.)
34. Benchimol, M., C. Batista, and W. de Souza. 1990. Fibronectin-and laminin-mediated endocytic activity in the parasitic protozoa Trichomonas vaginalis and Tritrichomonas foetus. J. Submicrosc. Cytol. Pathol. 22:39-45.
35. Benchimol, M., and W. de Souza. 1983. Fine structure and cytochemistry of the hydrogenosome of Tritrichomonas foetus. J. Protozool. 30:422-425.
36. Benchimol, M., and W. de Souza. 1995. Carbohydrate involvement in the association of a prokaryotic cell with Trichomonas vaginalis and Tritrichomonas foetus. Parasitol. Res. 81:459-464.
37. Benchimol, M., P. J. Johnson, and W. de Souza. 1996. Morphogenesis of the hydrogenosome: an ultrastructural study. Biol. Cell 87:197-205.
38. Berggren, O. 1969. Association of carcinoma of the uterine cervix and Trichomonas vaginalis infestations. Frequency of Trichomonas vaginalis in preinvasive and invasive cervical carcinoma. Am. J. Obstet. Gynecol. 105:166-168.
39. Birnbaum, H., and E. Kraussold. 1975. Incidence of the blastomyces and trichomonad infections during the use of hormonal and intrauterine contraception. Zentralbl. Gynaekol. 97:1636-1640. (In German.)
40. Bonilha, V. L., M. Ciavaglia, W. de Souza, and F. Costa e Silva Filho. 1995. The involvement of terminal carbohydrates of the mammalian cell surface in the cytoadhesion of trichomonads. Parasitol. Res. 81:121-126.
41. Borchardt, K., M. Zhang, and H. Shing. 1996. A comparison of the sensitivity of the Inpouch Diamond's and Trichosel media for the detection of Trichomonas vaginalis, abstr C-120. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
42. Bouree, P., and C. Issoire. 1992. In vitro evaluation of the activity of butoconazole against Trichomonas vaginalis. Pathol. Biol. 40:492-494. (In French.)
43. Bozner, P. 1997. Immunological detection and subcellular localization of Hsp70 and Hsp60 homologs in Trichomonas vaginalis. J. Parasitol. 83:224-229.
44. Bramley, M., and G. Kinghorn. 1979. Do oral contraceptives inhibit Trichomonas vaginalis? Sex. Transm. Dis. 6:261-263.
45. Brasseur, P., and J. Savel. 1982. Evaluation of the virulence of Trichomonas vagina/is strains by the study of their cytopathogenic effect on cultured cells. C. R. Seances Soc. Biol. Fil. 176:849-860.
46. Bremner, A. F., G. H. Coombs, and M. J. North. 1987. Antitrichomonal activity of α-diflouromethylornithine. J. Antimicrob. Chemother. 20:405-411.
47. Briseiden, A. M., and S. L. Hillier. 1994. Evaluation of Affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 32:148-152.
48. Brown, M. T. 1972. Trichomoniasis. Practitioner 209:639-644.
49. Brugerolle, G. 1971. Demonstration of the endocytosis process and lysosome structures in Trichomonas vaginalis. C. R. Hebd. Seances Acad. Sci. Ser. D 272:2-60.
50. Brugerolle, G. 1975. Etude de la cryptopleuromitose et de la morphogenese de division chez Trichomonas vaginalis et chez pleusiers genres de trichomonadines primitives. Protistologica 11:457-468.
51. Cameron, D. W., and N. S. Padian. 1990. Sexual transmission of HIV and the epidemiology of other sexually transmitted diseases. AIDS 4(Suppl. 1):S99-S103.
52. Cappuccinelli, P., I. Cagliani, and G. Cavallo. 1975. Involvement of a surface concanavalin A-binding glycoprotein in the adhesion of Trichomonas vaginalis to substrates. Experientia 31:1157-1159.
53. Cappuccinelli, P., C. Lattes, I. Cagliani, and A. Negro Ponzi. 1974. Features of intravaginal Trichomonas vaginalis infection in the mouse and the effect of oestrogen treatment and immunodepression. Batteriol. Virol. Immunol. Ann. Osp. Maria Vittoria Torino I 67:31-40.
54. Cappuccinelli, P., C. Sellitto, D. Zicconi, and C. Juliano. 1987. Structural and molecular organization of Trichomonas vaginalis cytoskeleton. Acta Univ. Carol. Biol. 30(314):211-217. (Abstract.)
55. Catterall, R. D. 1972. Trichomonal infections of the genital tract. Med. Clin. North Am. 56:1203-1209.
56. Catterall, R. D., and C. S. Nicol. 1960. Is trichomonal infestation a venereal disease? Br. Med. J. 1:1177.
57. Cavalier-Smith, T. 1987. Eukaryotes with no mitochondria. Nature 326:332-333.
58. Cavier, R. E., J. G. Cobort, and J. Savel. 1972. Application of a method of intraperitoneal infection of the mouse with Trichomonas vaginalis for the pharmacological study of trichomonacides. Ann. Pharm. Fr. 30:637-642. (In French.)
59. Chapman, A., D. Linstead, D. Lloyd, and J. Williams. 1987. 13C-NMR reveals glycerol as a unexpected major metabolite of the protozoan parasite Trichomonas vaginalis. FEBS Lett. 191:287-292.
60. Chaudhuri, P., and A. C. Drogendijk. 1980. A double-blind controlled clinical trial of carnidazole and tinidazolc in the treatment of vaginal trichomoniasis. Eur. J. Obstet. Gynecol. Rep. Biol. 10:325-328.
61. Chen, J. F., W. L. Chen, P. Liang, and X. R. Zhong. 1992. Ultracytochemical studies on Trichomonas hominis. Chin. Med. J. 105:1009-1013.
62. Choromanski, L., D. A. Beat, J. H. Nordin, A. A. Pan, and B. M. Honigberg. 1985. Further studies on the surface saccharides in Trichomonas vaginalis strains by fluorescein-conjugated lectins. Z. Parasitenkd. 71:443-458.
63. Christian, R. T., N. F. Miller, P. P. Ludovic, and G. M. Riley. 1963. A study of Trichomonas vaginalis in human cell culture. Am. J. Obstet. Gynecol. 85:947-954.
64. Cogne, M., P. Brasseur, and J. J. Ballet. 1985. Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis. J. Clin. Microbiol. 21:588-592.
65. Corbeil, L. B. 1995. Use of an animal model of trichomoniasis as a basis for understanding this disease in women. Clin. Infect. Dis. 21(Suppl. 2):S158-S161.
66. Cosar, C., and L. Julou. 1959. Activity of 1-(2′-hydroxyethyl)-2-methyl-5-nitroimidazole (8823 RP) against experimental Trichomonas vaginalis infection. Ann. Inst. Pasteur 96:238-241.
67. Costa e Silva Filho, F., E. M. Breier-Saraiva, M. X. Tosta, and W. de Souza. 1989. Trichomonas vaginalis and Tritrichomonas foetus secrete neuraminidase into the culture medium. Mol. Biochem. Parasitol. 35:73-78.
68. Costa e Silva Filho, F., W. de Souza, and J. D. Lopes. 1988. Presence of laminin-binding proteins in trichomonads and their role in adhesion. Proc. Natl. Acad. Sci. USA 85:8042-8046.
69. Costello, C. E., J. Glushka, H. van Halbeek, and B. N. Singh. 1993. Structural characterization of novel inositol phosphosphingolipids of Tritrichomonas foetus and Trichomonas vaginalis. Glycobiology 3:261-269.
70. Cotch, M. F. 1990. Carriage of Trichomonas vaginalis (Tv) is associated with adverse pregnancy outcome, abstr. 681, p. 199. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
71. Dailey, D. C., and J. F. Alderete. 1991. The phenotypically variable surface protein of Trichomonas vaginalis has a single, tandemly repeated immuno-dominant epitope. Infect. Immun. 59:2083-2088.
72. Dailey, D. C., T. H. Chang, and J. F. Alderete. 1990. Characterization of Trichomonas vaginalis haemolysis. Parasitology 101:171-175.
73. Daly, J. J., J. K. Shernan, T. Haley, and T. L. Hostetler. 1990. Difference in effect of dog seminal fluid and human seminal fluid and semen on in vitro survival of Trichomonas vaginalis. Sex. Transm. Dis. 17:106-109.
74. Davis, S. R., and W. B. Lushbaugh. 1992. Characterization of the heat-shock response of Trichomonas vaginalis. Am. J. Trop. Med. Hyg. 47:70-77.
75. Davis, S. R., and W. B. Lushbaugh. 1993. Oxidative stress and Trichomonas vaginalis: the effect of hydrogen peroxide in vitro. Am. J. Trop. Med. Hyg. 48:480-487.
76. de Carli, G. A., P. Brasseur, M. Rott, A. da Silva, and A. Wendorff. 1994. Hemolytic activity of various strains and clones of Trichomonas vaginalis and Tritrichomonas suis. Rev. Latinoam. Microbiol. 36:207-211. (In Spanish.)
77. Demes, P., A. Gombosova, M. Valent, H. Fabusova, and A. Janoska. 1988. Fewer Trichomonas vaginalis organisms in vaginas of infected women during menstruation. Genitourin. Med. 64:22-24.
78. Demes, P., A. Gombosova, M. Valent, A. Janoska, H. Fabusova, and M. Petrenko. 1988. Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus. Genitourin. Med. 64:176-179.
79. Diamond, L. S. 1957. The establishment of various trichomonads of animals and man in axenic cultures. J. Parasitol. 43:488-490.
80. Diamond, L. S. 1968. Techniques of axenic cultivation of Entamoeba histolylica Schaudinn, 1903 and E. histolytica-like amebae. J. Parasitol. 54:1047-1056.
81. Diamond, L. S. 1986. In vitro cultivation of the Trichomonadidae: a state of the art review. Acta Univ. Carol.-Biol. 30:221-228.
82. Diamond, L. S., C. G. Clark, and C. C. Cunnick. 1995. YI-S, a casein-free medium for axenic cultivation of Entamoeba histolytica, related Entamoeba, Giardia intestinalis and Trichomonas vaginalis. J. Eukaryot. Microbiol. 42:277-278.
83. Diamond, L. S., D. H. Harlow, and C. C. Cunnick. 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72:431-432.
84. Dias Filho, B. P., A. F. Andrade, W. de Souza, M. J. Esteves, and J. Angluster. 1992. Cell surface saccharide differences in drug-susceptible and drug-resistant strains of Trichomonas vaginalis. Microbios 71:55-64.
85. Donné, M. A. 1836. Animacules observes dans les matieres purulentes et le produit des secretions des organes genitaux de l'homme et de la femme. C. R. Acad. Sci. 3:385-386.
86. Edwards, D. I., E. J. Thompson, J. Tomusange, and D. Hanson. 1979. Inactivation of metronidazole by aerobic organisms. J. Antimicrob. Chemother. 5:315-316.
87. Engbring, J. A., J. L. O'Brien, and J. F. Alderete. 1996. Trichomonas vaginalis adhesins display molecular mimicry to metabolic enzymes. Adv. Exp. Med. Biol. 408:207-223.
88. Fari, A., R. Trevoux, and V. Verges. 1985. Diagnosis and significance of non-motile forms of Trichomonas vaginalis, abstr. 28a. In Abstracts of the International Symposium on trichomonads and Trichomoniasis.
89. Farris, V. K., and B. M. Honigberg. 1970. Behaviour and pathogenicity of Trichomonas vaginalis Donné in chick liver cells. J. Parasitol. 56:849-882.
90. Fiori, P. L., P. Rappelli, A. M. Rocchigiani, and P. Cappuccinelli. 1993. Trichomonas vaginalis haemolysis: evidence of functional pores formation on red cell membranes. FEMS Microbiol. Lett. 109:13-18.
91. Fouts, A. C., and S. J. Kraus. 1980. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 141:137-143.
92. Fripp, P. J., P. R. Mason, and H. Super. 1975. A method for the diagnosis of Trichomonas vaginalis using acridine orange. J. Parasitol. 61:966-967.
93. Fugere, P., G. Verschelden, and M. Caron. 1983. Single oral dose of ornidazole in women with vaginal trichomoniasis. Obstet. Gynecol. 62:502-505.
94. Garber, G. E., and W. R. Bowie. 1990. The effect of Trichomonas vaginalis and the role of pH on cell culture monolayer viability. Clin. Invest. Med. 13:71-76.
95. Garber, G. E., and L. T. Lemchuk-Favel. 1989. Characterization and purification of extracellular proteases of Trichomonas vaginalis. Can. J. Microbiol. 35:903-909.
96. Garber, G. E., and L. T. Lemchuk-Favel. 1990. Association of production of cell-detaching factor with the clinical presentation of Trichomonas vaginalis. J. Clin. Microbiol. 28:2415-2417.
97. Garber, G. E., and L. T. Lemchuk-Favel. 1994. Analysis of the extracellular proteases of Trichomonas vaginalis. Parasitol. Res. 80:361-365.
98. Garber, G. E., L. T. Lemchuk-Favel, and W. R. Bowie. 1989. Isolation of a cell-detaching factor of Trichomonas vaginalis. J. Clin. Microbiol. 27:1548-1553.
99. Garber, G. E., L. T. Lemchuk-Favel, and G. Rousseau. 1991. Effect of beta-estradiol on production of the cell-detaching factor of Trichomonas vaginalis. J. Clin. Microbiol. 29:1847-1849.
100. Garber, G. E., E. M. Proctor, and W. R. Bowie. 1986. Immunogenic proteins of Trichomonas vaginalis as demonstrated by the immunoblot technique. Infect. Immun. 51:250-253.
101. Garber, G. E., L. Sibau, R. Ma, E. M. Proctor, C. E. Shaw, and W. R. Bowie. 1987. Cell culture compared with broth for detection of Trichomonas vaginalis. J. Clin. Microbiol. 25:1275-1279.
102. Garcia-Tamayo, J., J. T. Nunez-Montiel, and H. P. de Garcia. 1978. An electron microscopic investigation on the pathogenesis of human vaginal trichomoniasis. Acta Cytol. 22:447-455.
103. Gardner, W. A., Jr., D. E. Culberson, J. M. Scimeca, A. G. Brady, F. F. Pindak, and C. R. Abee. 1987. Experimental genital trichomoniasis in the squirrel monkey (Saimiri sciureus). Genitourin. Med. 63:188-191.
104. Germot, A., H. Philippe, and H. Le Guyader. 1996. Presence of a mitochondrial-type 70-kDa heat shock protein in Trichomonas vaginalis suggests a very early mitochondrial endosymbiosis in eukaryotes. Proc. Natl. Acad. Sci. USA 93:14614-14617.
105. Gillin, F. D., and A. Sher. 1981. Activation of the alternative complement pathway by Trichomonas vaginalis. Infect. Immun. 34:268-273.
106. Glaser, R. W., and N. A. Coria. 1935. Purification and culture of Tritrichomonas foetus (Ried-Muller) from cows. J. Parasitol. 32:1211-1215.
107. Gold, D., and I. Ofek. 1992. Adhesion of Trichomonas vaginalis to plastic surfaces: requirement for energy and serum constituents. Parasitology 105:55-62.
108. Gombosova, A., P. Demes, and M. Valent. 1986. Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis. Genitourin. Med. 62:107-110.
109. Gorrell, T. E. 1985. Effect of culture medium iron content on the biochemical composition and metabolism of Trichomonas vaginalis. J. Bacteriol. 161:1228-1230.
110. Gram, I., M. Macaluso, J. Churchill, and H. Stalsberg. 1992. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 3:231-236.
111. Grodstein, F., M. B. Goldman, and D. W. Cramer. 1993. Relation of tubal infertility to a history of sexually transmitted diseases. Am. J. Epidemiol. 137:577-584.
112. Grys, E. 1973. Diagnosis of trichomonadosis in the urinary tract of women (preliminary report). Wiad. Parazytol. 19:461-462. (In Polish.)
113. Gunderson, J., G. Hinkle, D. Leipe, H. G. Morrison, S. K. Stickel, D. A. Odelson, T. A. Nerad, M. Muller, and M. L. Sogin. 1995. Phylogeny of trichomonads inferred from small-subunit rRNA sequences. J. Eukaryot. Microbiol. 42:411-415.
114. Hager, W. D., S. T. Brown, S. J. Kraus, G. S. Kleris, G. J. Perkins, and M. Henderson. 1980. Metronidazole for vaginal trichomoniasis: seven-day vs. single-dose regimen. JAMA 244:1219-1220.
115. Hardy, P. H., J. B. Hardy, E. E. Nell, D. A. Graham, M. R. Spence, and R. C. Rosenbaum. 1984. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet ii:333-337.
116. Harris, D. I., R. B. Beechey, D. Linstead, and J. Barrett. 1988. Nucleoside uptake by Trichomonas vaginalis. Mol. Biochem. Parasitol. 29:105-116.
117. Hayward, M. J., and R. B. Roy. 1976. Two-day treatment of trichomoniasis in the female. Comparison of metronidazole and nimorazole. Br. J. Vener. Dis. 52:63-64.
118. Heath, J. P. 1981. Behaviour and pathogenicity of Trichomonas vaginalis in epithelial cell cultures: a study by light and scanning electron microscopy. Br. J. Vener. Dis. 57:106-117.
119. Heine, P., and J. A. McGregor. 1993. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36:137-144.
120. Heyworth, P. G., W. E. Gutteridge, and C. D. Ginger. 1982. Purine metabolism in Trichomonas vaginalis. FEBS Lett. 141:106-110.
121. Heyworth, P. G., W. E. Gutteridge, and C. D. Ginger. 1984. Pyrimidine metabolism in Trichomonas vaginalis. FEBS Lett. 176:55-60.
122. Hogue, M. J. 1943. The effect of Trichomonas vaginalis on tissue culture cells. Am. J. Hyg. 37:142-152.
123. Hollander, D. H., and J. D. Gonder. 1985. Indigenous intravaginal pentatrichomonads vitiate the usefulness of squirrel monkeys (Saimiri sciurius) as models for human trichomoniasis in men. Genitourin. Med. 61:212.
124. Holmes, K. K., H. H. Handsfield, S. P. Wang, B. B. Wentworth, M. Turck, J. B. Anderson, and E. R. Alexander. 1975. Etiology of nongonococcal urethritis. N. Engl. J. Med. 292:1199-1205.
125. Honigberg, B. M. 1978. Trichomonads of importance in human medicine, p. 275-454. In J. P. Kreiger (ed.), Parasitic protozoa. Academic Press, Inc., New York, N.Y.
126. Honigberg, B. M. 1987. Immunology of trichomonads, with emphasis on Trichomonas vaginalis. Acta Univ. Carol.-Biol. 10:321-336.
127. Honigberg, B. M., and G. Brugerolle. 1990. Structure, p. 5-35. In B. M. Honigberg, (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
128. Honigberg, B. M., and A. C. Ewalt. 1961. Preliminary observations on pathogenicity of Trichomonas vaginalis for cell cultures. Int. Congr. Protozool. 1:568-569.
129. Honigberg, B. M., P. K. Gupta, M. R. Spence, J. K. Frost, K. Kuczynska, L. Choromanski, and A. Warton. 1984. Pathogenicity of Trichomonas vaginalis: cytopathologic and histopathologic changes of the cervical epithelium. Obstet. Gynecol. 64:179-184.
130. Honigberg, B. M., and V. M. King. 1964. Structure of Trichomonas vaginalis Donne. J. Parasitol. 50:345-364.
131. Honigberg, B. M., M. C. Livingstone, and J. K. Frost. 1966. Pathogenicity of fresh isolates of Trichomonas vagina/is. The "mouse assay" versus clinical and pathologic findings. Acta Cytol. 10:353-361.
132. Honigberg, B. M., D. Volkmann, R. Entzeroth, and E. Scholtyseck. 1984. A freeze-fracture electron microscope study of Trichomonas vaginalis Donne and Tritrichomonas foetus (Riedmuller). J. Protozool. 31:116-131.
133. Horner, D. S., R. P. Hirt, S. Kilvington, D. Lloyd, and T. M. Embley. 1996. Molecular data suggest an early aquisition of the mitochondrion endosymbiont. Proc. R. Soc. London Ser. B 263:1053-1059.
134. Hrdy, I., E. Mertens, and E. Van Schaftingen. 1993. Identification, purification and separation of different isoenzymes of NADP-specific malic enzyme from Tritrichomonas foetus. Mol. Biochem. Parasitol. 57:253-260.
135. Huggins, G. R., and G. Preti. 1981. Vaginal odours and secretions. Clin. Obstet. Gynecol. 24:355-376.
136. Hulka, B. S., and J. F. Hulka. 1967. Dyskaryosis in cervical cytology and its relationship to trichomoniasis therapy. A double blind study. Am. J. Obstet. Gynecol. 98:180-187.
137. Ingham, H. R., C. J. Hall, P. R. Sisson, D. Tharagonnet, and J. B. Selkon. 1979. Inactivation of metronidazole by aerobic organisms. J. Antimicrob. Chemother. 5:734-735.
138. Iovannisci, D. M., K. Kaur, L. Young, and B. Ullman. 1984. Genetic analysis of nucleoside transport in Leishmania donovani. Mol. Cell. Biol. 4:1013-1019.
139. Irvine, J. W., G. H. Coombs, and M. J. North. 1993. Purification of cysteine proteinases from trichomonads using bacitracin-Sepharose. FEMS Microbiol. Lett. 110:113-119.
140. Irvine, J. W., M. J. North, and G. H. Coombs. 1997. Use of inhibitors to identify essential cysteine proteinases of Trichomonas vaginalis. FEMS Microbiol. Lett. 149:45-50.
141. Ivey, M. H., and D. G. Hall. 1964. Virulence of different strains of Trichomonas vaginalis in the mouse. Am. J. Trop. Med. Hyg. 13:16-19.
142. Jaakmees, H., J. Teras, E. Roigas, U. Nigesen, and H. Tompel. 1966. Complement-fixing antibodies in the blood sera of men infested with Trichomonas vaginalis. Wiad. Parazytol. 12:378-384. (In Polish.)
143. Jirovec, O., and M. Petru. 1968. Trichomonas vaginalis and trichomoniasis. Adv. Parasitol. 6:117-188.
144. Jitpraphai, P., and G. J. Wise. 1971. Pathogenicity of Trichomonas vaginalis in the genito-urinary tract of experimental male animals. J. Med. Assoc. Thail. 54:714-726.
145. Johnson, P. J., C. E. d'Oliveira, T. E. Gorrell, and M. Muller. 1990. Molecular analysis of the hydrogenosomal ferredoxin of the anaerobic protist Trichomonas vaginalis. Proc. Natl. Acad. Sci. USA 87:6097-6101.
146. Johnson, P. J., C. J. Lahti, and P. J. Bradley. 1993. Biogenesis of the hydrogenosome in the anaerobic protist Trichomonas vaginalis. J. Parasitol. 79:664-670.
147. Johnson, P. J., B. L. Schuck, and M. G. Delgadillo. 1994. Analysis of a single-domain P-glycoprotein-like gene in the early-diverging protist Trichomonas vaginalis. Mol. Biochem. Parasitol. 66:127-137.
148. Juliano, C., G. Monaco, P. Bandiera, G. Tedde, and P. Cappuccinelli. 1987. Action of anticytoskeletal compounds on in vitro cytopathic effect, phagocytosis, and adhesiveness of Trichomonas vaginalis. Genitourin. Med. 63:256-263.
149. Kane, P. O., J. A. McFadzean, and S. Squires. 1961. Absorption and excretion of metronidazole. II. Studies on primary failures. Br. J. Vener. Dis. 37:276-277.
150. Kaufman, R. H., E. G. J. Freidrich, and H. L. Gardner. 1989. Benign diseases of the vulva and vagina, p. 382-400. Yearbook Medical Publishers, Inc., Chicago, Ill.
151. Kerscher, L., and D. Oesterhelt. 1982. Pyruvate:ferredoxin oxidoreductase - new findings on an ancient enzyme. Trends Biochem. Sci. 7:371-374.
152. Kharsany, A. B., A. A. Hoosen, J. Moodley, J. Bagaratee, and E. Gouws. 1993. The association between sexually transmitted pathogens and cervical intra-epithelial neoplasia in a developing community. Genitourin. Med. 69:357-360.
153. Khoshnan, A., and J. F. Alderete. 1993. Multiple double-stranded RNA segments are associated with virus particles infecting Trichomonas vaginalis. J. Virol. 67:6950-6955.
154. Khoshnan, A., and J. F. Alderete. 1994. Trichomonas vaginalis with a double-stranded RNA virus has upregulated levels of phenotypically variable immunogen mRNA. J. Virol. 68:4035-4038.
155. Khoshnan, A., and J. F. Alderete. 1995. Characterization of double-stranded RNA satellites associated with the Trichomonas vaginalis virus. J. Virol. 69:6892-6897.
156. Knodler, L. A., M. R. Edwards, and P. J. Schofleld. 1994. The intracellular amino acid pools of Giardia intestinalis, Trichomonas vaginalis, and Crithidia luciliae. Exp. Parasitol. 79:117-125.
157. Kon, V. B., J. M. Papadimitriou, T. A. Robertson, and A. Warton. 1988. Quantitation of concanavalin A and wheat germ agglutinin binding by two strains of Trichomonas vaginalis of differing pathogenicity using gold particle-conjugated lectins. Parasitol. Res. 75:7-13.
158. Krieger, J. N. 1981. Urologie aspects of trichomoniasis. Invest. Urol. 18:411-417.
159. Krieger, J. N. 1984. Prostatitis syndromes: pathophysiology, differential diagnosis, and treatment. Sex. Transm. Dis. 11:100-112.
160. Krieger, J. N. 1990. Epidemiology and clinical manifestations of urogenital trichomoniasis in men, p. 235-245. In B. M. Honigberg (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
161. Krieger, J. N. 1995. Trichomoniasis in men: old issues and new data. Sex. Transm. Dis. 22:83-96.
162. Krieger, J. N., K. K. Holmes, M. R. Spence, M. F. Rein, W. M. McCormack, and M. R. Tam. 1985. Geographic variation among isolates of Trichomonas vaginalis: demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique. J. Infect. Dis. 152:979-984.
163. Krieger, J. N., M. A. Poisson, and M. F. Rein. 1983. Beta-hemolytic activity of Trichomonas vaginalis correlates with virulence. Infect. Immun. 41:1291-1295.
164. Krieger, J. N., J. L. Ravdin, and M. F. Rein. 1985. Contact-dependant cytopathogenic mechanisms of Trichomonas vaginalis. Infect. Immun. 50:778-786.
165. Krieger, J. N., and M. F. Rein. 1982. Canine prostatic secretions kill Trichomonas vaginalis. Infect. Immun. 37:77-81.
166. Krieger, J. N., P. Wolner-Hanssen, C. Stevens, and K. K. Holmes. 1990. Characteristics of Trichomonas vaginalis isolates from women with and without colpitis macularis. J. Infect. Dis. 161:307-311.
167. Kulda, J. 1967. Effects of different species of trichomonads on monkey kidney cell culture. Folia Parasitol. 14:295-310.
168. Kulda, J. 1990. Experimental animals in studies of T. vaginalis infection, p. 112-153. In B. M. Honigberg, (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
169. Kulda, J., and B. M. Honigberg. 1969. Behavior and pathogenicity of Tritrichomonas foetus in chick liver cell cultures. J. Protozool. 16:479-495.
170. Kulda, J., J. Tachezy, and A. Cerkasovova. 1993. In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis. J. Eukaryot. Microbiol. 40:262-269.
171. Laga, M., M. Alary, N. Nzila, A. T. Manoka, M. Tuliza, F. Behets, J. S. Goeman, M. Louis, and P. Piot. 1994. Condom promotion, sexually transmitted disease treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 344:246-248.
172. Laga, M., A. Manoka, M. Kivuvu, B. Malele, M. Tuliza, N. Nzila, J. B. Goeman, F. V. Batter, M. Alary, et al. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95-102.
173. Laga, M., N. Nzila, and J. Goeman. 1991. The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa. AIDS 5(Suppl. 1):S55-S63.
174. Lahti, C. J., C. E. d'Oliveira, and P. J. Johnson. 1992. Beta-succinylcoenzyme A synthetase from Trichomonas vaginalis is a soluble hydrogenosomal protein with an amino-terminal sequence that resembles mitochondrial presequences. J. Bacteriol. 174:6822-6830.
175. Landolfo, S., M. G. Martinotti, P. Martinetto, and G. Forni. 1980. Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. J. Immunol. 124:508-514.
176. Lehker, M. W., and J. F. Alderete. 1990. Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions. Genitourin. Med. 66:193-199.
177. Lehker, M. W., R. Arroyo, and J. F. Alderete. 1991. The regulation by iron of the synthesis of adhesins and cytadherence levels in the protozoan Trichomonas vaginalis. J. Exp. Med. 174:311-318.
178. Lehker, M. W., T. H. Chang, D. C. Dailey, and J. F. Alderete. 1990. Specific erythrocyte binding is an additional nutrient acquisition system for Trichomonas vaginalis. J. Exp. Med. 171:2165-2170.
179. Levett, P. N. 1980. A comparison of five methods for the detection of Trichomonas vaginalis in clinical specimens. Med. Lab. Sci. 37:85-88.
180. Levi, M. H., J. Torres, A. Winston, C. Pina, and R. S. Klein. 1996. Comparison of the InPouch system [IP] to Diamonds modified medium [DMM] for the isolation of Trichomonas vaginalis [Tv]. abstr. C-110, p. 20. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
181. Lindmark, D. G., B. L. Eckenrode, L. A. Halberg, and I. D. Dinbergs. 1989. Carbohydrate, energy and hydrogenosomal metabolism of Tritrichomonas foetus and Trichomonas vaginalis. J. Protozool. 36:214-216.
182. Lindmark, D. G., and M. Muller. 1973. Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J. Biol. Chem. 248:7724-7728.
183. Lindmark, D. G., M. Muller, and H, Shio. 1975. Hydrogenosomes in Trichomonas vaginalis. J. Parasitol. 61:522-554.
184. Linstead, D. 1981. New defined and semi-defined media for cultivation of the flagellate Trichomonas vaginalis. Parasitology 83:125-137.
185. Lirosi, G., and A. Guarascio. 1972. Effects of hormonal changes in the vaginal environment in the treatment of vaginitis especially due to Trichomonas. Minerva Ginecol. 24:23-27.
186. Lisi, P. J., R. S. Dondero, D. Kwiatkoski, M. R. Spence, M. F. Rein, and J. F. Alderete. 1988. Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis. J. Clin. Microbiol. 26:1684-1686.
187. Lockwood, B. C., M. J. North, K. I. Scott, A. F. Bremner, and G. H. Coombs. 1987. The use of a highly sensitive electrophoretic method to compare the proteinases of trichomonads. Mol. Biochem. Parasitol. 24:89-95.
188. Lopes, J. D., G. F. Da-Mota, C. R. Carneiro, L. Gomes, and F. Costa e Silva Filho. 1988. Evolutionary conservation of laminin-binding proteins. Braz. J. Med. Biol. Res. 21:1269-1273.
189. Lossick, J. G. 1982. Treatment of Trichomonas vaginalis infections. Rev. Infect. Dis. 4:S801-S818.
190. Lossick, J. G., and H. L. Kent 1991. Trichomoniasis: trends in diagnosis and management. Am. J. Obstet. Gynecol. 165:1217-1222.
191. Lossick, J. G., M. Muller, and T. E. Gorrell. 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153:948-955.
192. Lowe, P. N., and A. F. Rowe. 1986. Aminotransferase activities in Trichomonas vaginalis. Mol. Biochem. Parasitol. 21:65-74.
193. Lumsden, W. H. R., D. H. H. Robertson, R. Heyworth, and C. Harrison. 1988. Treatment failure in Trichomonas vaginalis vaginitis. Genitourin. Med. 64:217-218.
194. Mack, S. R., and M. Muller. 1980. End products of carbohydrate metabolism in Trichomonas vaginalis. Comp. Biochem. Physiol. 67:213-216.
195. Mallinson, D. J., B. C. Lockwood, G. H. Coombs, and M. J. North. 1994. Identification and molecular cloning of four cysteine proteinase genes from the pathogenic protozoon Trichomonas vaginalis. Microbiology 140:2725-2735.
196. Manson, P. R. 1979. Serodiagnosis of Trichomonas vaginalis infection by indirect fluorescent antibody test. J. Parasitol. 32:1211-1215.
197. Marczak, R., T. E. Gorrell, and M. Muller. 1983. Hydrogenosomal ferredoxin of the anaerobic protozoon, Tritrichomonas foetus. J. Biol. Chem. 258:12427-12433.
198. Mardh, P. A., and S. Colleen. 1975. Search for uro-genital tract infections in patients with symptoms of prostatitis. Studies on aerobic and strictly anaerobic bacteria, mycoplasmas, fungi, trichomonads and viruses. Scand. J. Urol. Nephrol. 9:8-16.
199. Martin, R. D., R. H. Kaufman, and M. Burns. 1963. Trichomonas vaginalis: a statistical evaluation of diagnostic methods. Am. J. Obstet. Gynecol. 87:1024-1027.
200. Martinotti, M. G., P. Martinetto, and D. Savoia. 1986. Adherence of Trichomonas vaginalis to cell culture monolayers. Eur. J. Clin. Microbiol. 5:320-323.
201. Mason, P. R. 1979. Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent antibody test. J. Clin. Pathol. 32:1211-1215.
202. Mathews, H. M., and G. R. Healy. 1983. Evaluation of two serological tests for Trichomonas vaginalis infection. J. Clin. Microbiol. 17:840-843.
203. McCann, J. S. 1974. Comparison of direct microscopy and culture in the diagnosis of trichomoniasis. Br. J. Vener. Dis. 50:450-452.
204. McCormack, W. 1974. Sexually transmissible conditions other than gonorrhoea and syphilis, p. 1-16. In F. Tice and L. H. Sloan. (ed.), Practice of medicine. Harper & Row, Publishing Co., New York, N.Y.
205. McFadzean, J. A., I. M. Pugh, S. L. Squires, and J. P. F. Whelan. 1969. Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole. Br. J. Vener. Dis. 45:161-162.
206. McGrory, T., and G. E. Garber. 1992. Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection. Infect. Immun. 60:2375-2379.
207. McGrory, T., K. C. Meysick, L. T. Lemchuk-Favel, and G. E. Garber. 1994. The interaction of Lactobacillus acidophilus and Trichomonas vaginalis in vitro. J. Parasitol. 80:50-54.
208. McLellan, R., M. R. Spence, M. Brockman, L. Raffel, and J. L. Smith. 1982. The clinical diagnosis of trichomoniasis. Obstet. Gynecol. 60:30-34.
209. Meingassner, J. G. 1977. Comparative studies in the trichomonacidal activity of 5-nitroimidazole derivatives in mice infected s.c. or intravaginally with T. vaginalis. Experientia 33:1160-1161.
210. Meysick, K. C., K. Dimock, and G. E. Garber. 1996. Molecular characterization and expression of a N-acetylneuraminate lyase gene from Trichomonas vaginalis. Mol. Biochem. Parasitol. 76:289-292.
211. Meysick, K. C., and G. E. Garber. 1990. Growth of Trichomonas vaginalis in a serum-free McCoy cell culture system. J. Parasitol. 76:926-928.
212. Meysick, K. C., and G. E. Garber. 1992. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model. J. Parasitol. 78:157-160.
213. Miller, R. L., and D. Lindstead. 1983. Purine and pyrimidine metabolizing activities in Trichomonas vaginalis extracts. Mol. Biochem. Parasitol. 7:41-51.
214. Minkoff, H., A. N. Grunebaum, R. H. Schwarz, J. Feldman, M. C. Cummings, W. L. Clark, G. Pringle, and W. M. McCormack. 1984. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am. J. Obstet. Gynecol. 150:965-972.
215. Moldwin, R. M. 1992. Sexually transmitted protozoal infections. Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia. Urol. Clin. North Am. 19:93-101.
216. Müller, M. 1980. The hydrogenosome. Symp. Soc. Gen. Microbiol. 30:127-142.
217. Müller, M. 1986. Reductive activation of nitroimidazoles in aerobic micro-organisms. Biochem. Pharmacol. 35:37-41.
218. Müller, M. 1987. Hydrogenosomes of trichomonad flagellates. Acta Univ. Carol. Biol. 30(3/4):249-260. (Abstract.)
219. Müller, M. 1988. Energy metabolism of protozoa without mitochondria. Annu. Rev. Microbiol. 42:465-488.
220. Müller, M. 1990. Biochemistry of Trichomonas vaginalis, p. 53-83. In B. M. Honigberg, (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
221. Müller, M. 1992. Energy metabolism of ancestral eukaryotes: a hypothesis based on the biochemistry of amitochondriate parasitic protists. Chin. Med. J. 28:33-40.
222. Müller, M., and R. G. Lindmark. 1976. Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions. Antimicrob. Agents Chemother. 9:696-700.
223. Müller, M., J. G. Lossick, and T. E. Gorrell. 1988. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. 15:17-24.
224. Nagesha, C. N., N. C. Ananthakrishna, and P. Sulochana. 1970. Clinical and laboratory studies on vaginal trichomoniasis. Am. J. Obstet. Gynecol. 106:933-935.
225. Narcisi, E. M., and W. E. Secor. 1996. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob. Agents Chemother. 40:1121-1125.
226. Neale, K. A., and J. F. Alderete. 1990. Analysis of the proteinases of representative Trichomonas vaginalis isolates. Infect. Immun. 58:157-162.
227. Nicoletti, N. 1961. The problem of trichomoniasis of the lower genital tract in the female. Br. J. Vener. Dis. 37:222-228.
228. Nielsen, M. H., and R. Nielsen. 1975. Electron microscopy of Trichomonas vaginalis Donne: interaction with vaginal epithelium in human trichomoniasis. Acta Pathol. Microbiol. Scand. Sect. B 83:305-320.
229. Nielsen, M. H. 1976. In vitro effect of metronidazole on the ultrastructure of Trichomonas vaginalis Donné. Acta Pathol. Microbiol. Scand. Sect. B 84:93-100.
230. North, M. J. 1982. Comparative biochemistry of the proteinases of eucaryotic microorganisms. Microbiol. Rev. 46:308-340.
231. North, M. J. 1994. Cysteine endopeptidases of parasitic protozoa. Methods Enzymol. 244:523-539.
232. O'Brien, J. L., C. Lauriano, and J. F. Alderete. 1996. Molecular character ization of a third malic enzyme-like AP65 adhesin gene of Trichomonas vaginalis. Microb. Pathog. 20:335-349.
233. Ovcinnikov, N. M., V. V. Delektorskij, E. N. Turanova, and G. N. Yashkova. 1975. Further studies of Trichomonas vaginalis with transmission and scanning electron microscopy. Br. J. Vener. Dis. 51:357-375.
234. Pereyra, A. J., R. M. Nelson, and D. J. Ludders. 1972. Flunidazole - a new drug for systemic treatment of urogenital trichomoniasis. Am. J. Obstet. Gynecol. 112:963-966.
235. Perl, G. 1972. Errors in the diagnosis of Trichomonas vaginalis infections as observed among 1199 patients. Obstet. Gynecol. 39:7-9.
236. Peterson, K. M., and J. F. Alderete. 1982. Host plasma proteins on the surface of pathogenic Trichomonas vaginalis. Infect. Immun. 37:755-762.
237. Peterson, K. M., and J. F. Alderete. 1984. Trichomonas vaginalis is dependent on uptake and degradation of human low density lipoproteins. J. Exp. Med. 160:1261-1272.
238. Peterson, K. M., and J. F. Alderete. 1984. Selective acquisition of plasma proteins by Trichomonas vaginalis and human lipoproteins as a growth requirement for this species. Mol. Biochem. Parasitol. 12:37-48.
239. Peterson, K. M., J. B. Baseman, and J. F. Alderete. 1987. Molecular cloning of Treponema pallidum outer envelope fibronectin binding proteins, P1 and P2. Genitourin. Med. 63:355-360.
240. Pindak, F. F., W. A. Gardner, Jr., and M. Mora de Pindak. 1986. Growth and cytopathogenicity of Trichomonas vaginalis in tissue cultures. J. Clin. Microbiol. 23:672-678.
241. Pindak, F. F., M. Mora de Pindak, and W. A. Gardner, Jr. 1993. Contact-independent cytotoxicity of Trichomonas vaginalis. Genitourin. Med. 69:35-40.
242. Plagemann, P. G. W., and R. M. Wohlheuter. 1982. Nucleoside and nucleobase uptake in cultured and animal cells, p. 245-250. In A. N. Martonosi (ed.), Membranes and transport. Plenum Press, New York, N.Y.
243. Provenzano, D., and J. F. Alderete. 1995. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infect. Immun. 63:3388-3395.
244. Quon, D. V., C. E. d'Oliveira, and P. J. Johnson. 1992. Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proc. Natl. Acad. Sci. USA 89:4402-4406.
245. Rasmussen, S. E., M. H. Nielsen, I. Lind, and J. M. Rhodes. 1986. Morphological studies of the cytotoxicity of Trichomonas vaginalis to normal human vaginal epithelial cells in vitro. Genitourin. Med. 62:240-246.
246. Rein, M. F. 1990. Clinical manifestations of urogenital trichomoniasis in women, p. 225-234. In B. M. Honigberg (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
247. Rein, M. F., and T. A. Chapel. 1975. Trichomoniasis, candidiasis, and the minor venereal diseases. Clin. Obstet. Gynecol. 18:73-88.
248. Rein, M. F., and K. K. Holmes. 1983. "Non-specific vaginitis", vulvovaginal candidiasis and trichomoniasis: clinical features, diagnosis and management, p. 281-315. In J. Remington and M. N. Swartz (ed.), Current clinical topics in infectious diseases. Blackwell Scientific Publications, New York, N.Y.
249. Riley, D. E, M. C. Roberts, T. Takayama, and J. N. Krieger. 1992. Development of a polymerase chain reaction based on diagnosis of Trichomonas vaginalis. J. Clin. Microbiol. 30:465-472.
250. Rodriguez-Martinez, H. A., M. De la Luz Rosales, L. Galloso de Bello, and J. A. Ruiz-Moreno. 1973. Adequate staining of Trichomonas vaginalis by McManus' periodic acid-Schiff stain. Am. J. Clin. Pathol. 59:741-746.
251. Roger, A. J., C. G. Clark, and W. F. Doolittle. 1996. A possible mitrochondrial gene in the early-branching amitochondriate protist Trichomonas vaginalis. Proc. Natl. Acad. Sci. USA 93:14618-14622.
252. Roigas, E., J. Teras, V. Ridala, and H. Tompel. 1969. Patho-morphological reaction of testicles of white rats and guinea pigs infected with Trichomonas vaginalis Donne. Wiad. Parazytol. 15:315-317. (In Polish.)
253. Rosa, F. W., C. Baum, and M. Shaw. 1987. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet. Gynecol. 69:751-755,
254. Roussel, F., G. A. de Carli, and P. Brasseur. 1991. A cytopathic effect of Trichomonas vaginalis probably mediated by a mannose/N-acetyl-glucosamine binding lectin. Int. J. Parasitol. 21:941-944.
255. Rowe, A. F., and P. N. Lowe. 1986. Modulation of amino acid and 2-oxo acid pools in Trichomonas vaginalis by aspartate aminotransferase inhibitors. Mol. Biochem. Parasitol. 21:17-24.
256. Rubino, S., R. Muresu, P. Rappelli, P. L. Fiori, P. Rizzu, and G. Erre. 1991. Molecular probe for identification of Trichomonas vaginalis DNA. J. Clin. Microbiol. 29:702-706.
257. Schwartz, M. 1987. The maltose regulon, p. 1482-1502. In F. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. G. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology. American Society for Microbiology, Washington, D.C.
258. Sebek, V. 1972. Trichomonas pyosalpinx. Cesk. Gynekol. 37:14-15. (In Czech.)
259. Semenza, G. 1987. Glycosidases, p. 265-287. In A. J. Kenny and A. J. Turner (ed.), Mammalian ectoenzymes. Elsevier Science Publishers, Amsterdam, The Netherlands.
260. Serrano, R. 1977. Energy requirements for maltose transport in yeast. Eur. J. Biochem. 80:97-102.
261. Shaio, M. F., P. R. Lin, and C. S. Lee. 1993. Killing of Trichomonas vaginalis by complement-mediated lysis is not associated with the presence of Trichomonas vaginalis virus. Int. J. Parasitol. 23:675-680.
262. Sharma, N. N., and B. M. Honigberg. 1966. Cytochemical observations on chick liver cell cultures infected with Trichomonas vaginalis. 1. Nucleic acids, polysaccharides, lipids, and proteins. J. Parasitol. 52:538-555.
263. Sharma, N. N., and B. M. Honigberg. 1969. Cytochemical observations on malic dehydrogenase, lipase, nonspecific esterase and monoamine oxidase in chick liver cell cultures infected with Trichomonas vaginalis. J. Protozool. 16:171-181.
264. Sharma, N. N., and B. M. Honigberg. 1971. Cytochemical observations on glucose-6-phosphatase, glucosan phosphorylase, glucose-6-phosphate dehydrogenase, and α-glycerophosphate dehydrogenase in chick liver cell cultures infected with Trichomonas vaginalis. Int. J. Parasitol. 1:67-83.
265. Sibau, L., D. Bebb, E. M. Proctor, and W. R. Bowie. 1987. Enzyme-linked immunosorbent assay for the diagnosis of trichomoniasis in women. Sex. Transm. Dis. 14:216-220.
266. Sikorski, R., Z. Hencner, Z. Glinski, K. Wawrzkiewicz, T. Radomanski, T. Paszkowski, W. Skrzypczak, P. Slawinski, and E. Maruszak. 1992. Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis. Wiad. Lek. 45:263-269. (In Polish.)
267. Singh, B. N., D. H. Beach, D. G. Lindmark, and C. E. Costello. 1994. Identification of the lipid moiety and further characterization of the novel lipophosphoglycan-like glycoconjugates of Trichomonas vaginalis and Tritrichomonas foetus. Arch. Biochem. Biophys. 309:273-280.
268. Singh, B. N., C. E. Costello, and D. H. Beach. 1991. Structures of glycophosphosphingolipids of Tritrichomonas foetus: a novel glycophosphosphingolipid. Arch. Biochem. Biophys. 286:409-418.
269. Spence, M. K., D. H. Hollander, J. Smith, L. McCaig, D. Sewell, and M. Brockman. 1980. The clinical and laboratory diagnosis of Trichomonas vaginalis infection. Sex. Transm. Dis. 7:168-171.
270. Spiegel, C. A. 1990. Microflora associated with Trichomonas vaginalis and vaccination against vaginal trichomoniasis, p. 213-224. In B. M. Honigberg (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
271. Steinbuchel, A., and M. Muller. 1986. Anaerobic pyruvate metabolism of Tritrichomonas foetus and Trichomonas vaginalis hydrogenosomes. Mol. Biochem. Parasitol. 20:57-65.
272. Steinbuchel, A., and M. Muller. 1986. Glycerol, a metabolic end product of Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 20:45-55.
273. Street, D. A., D. Taylor-Robinson, and C. M. Hetherington. 1983. Infection of female squirrel monkeys (Saimiri sciureus) with Trichomonas vaginalis as a model of trichomoniasis in women. Br. J. Vener. Dis. 59:249-254.
274. Street, D. A., C. Wells, D. Taylor-Robinson, and J. P. Ackers. 1984. Interaction between Trichomonas vaginalis and other pathogenic microorganisms of the human genital tract. Br. J. Vener. Dis. 60:31-38.
275. Street, D. A., D. Taylor-Robinson, J. P. Ackers, N. F. Hanna, and A. McMillan. 1982. Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions. Br. J. Vener. Dis. 58:330-333.
276. Su, H. M., and J. H. Tai. 1996. Genomic organization and sequence conservation in type 1 Trichomonas vaginalis viruses. Virology 222:470-473.
277. Su-Lin, K. E., and B. M. Honigberg. 1983. Antigenic analysis of Trichomonas vaginalis strains by quantitative fluorescent antibody methods. Z. Parasitenkd. 69:161-181.
278. Sucharit, P., A. Uthaischant, T. Chintana, W. Suphadtanapongs, P. Eamsobhana, and P. Prasomsitti. 1979. In vivo and in vitro studies of tinidazole in Trichomonas vaginaiis infection. S. E. Asian J. Trop. Med. Public Health 10:556-561.
279. Szreter, H. 1974. Phagocytosis of Neisseria gonorrhoeae by Trichomonas vaginalis (preliminary report). Wiad. Parazytol. 20:521-523. (In Polish.)
280. Szreter, H., and A. Delage. 1975. Atypical phagocytosis of starch grains by Trichomonas vaginalis. Wiad. Parazytol. 21:191-193. (In Polish.)
281. Szreter, H., and J. Kassner. 1990. Effect of Pseudomonas aeruginosa on Trichomonas vaginalis in vitro-electron-microscopic studies. Wiad. Parazytol. 36:187-191. (In Polish.)
282. Szreter, H., J. Kassner, and J. Michalczak. 1987. Phagocytosis of Streptococcus faecalis by Trichomonas vaginaiis. Electron microscopy studies. Wiad. Parazytol. 33:643-647. (In Polish.)
283. Tachezy, J., J. Kulda, and E. Tomkova. 1993. Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro. Parasitology 106:31-37.
284. Teras, J., U. Nigesen, H. Jaakmees, E. Roigas, and H. Tompel. 1966. The agglutinogenic properties of Trichomonas vaginalis in human organism. Wiad. Parazytol. 12:370-377. (In Polish.)
285. Teras, J., and E. Roigas. 1966. Characteristics of the patho-morphological reaction in cases of experimental infection with Trichomonas vaginalis. Wiad. Parazytol. 12:161-172. (In Polish.)
286. ter Kuile, B. H. 1994. Carbohydrate metabolism and physiology of the parasitic protist Trichomonas vaginalis studied in chemostats. Microbiology 140:2495-2502.
287. ter Kuile, B. H. 1994. Adaptation of the carbon metabolism of Trichomonas vaginalis to the nature and availability of the carbon source. Microbiology 140:2503-2510.
288. ter Kuile, B. H., and M. Muller. 1995. Maltose utilization by extracellular hydrolysis followed by glucose transport in Trichomonas vaginalis. Parasitology 110:37-44.
289. Thomas, D. D., J. B. Baseman, and J. F. Alderete. 1985. Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain. J. Exp. Med. 161:514-525.
290. Thomason, J. L., and S. M. Gelbart. 1989. Trichomonas vaginalis. Obstet. Gynecol. 74:536-541.
291. Thomason, J. L., and S. M. Gelbert. 1989. Trichomonas vaginalis. Obstet. Gynecol. 74:536-541.
292. Tocher, J. H., and D. I. Edwards. 1994. Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases. Biochem. Pharmacol. 48:1089-1094.
293. Tuttle, J. P., Jr., E. R. Bannister, and F. C. Derrick. 1977. Interference of human spermatozoal motility and spermatozoal agglutination by Candida albicans. J. Urol. 118:797-799.
294. Underbill, R. A., and J. E. Peck. 1974. Causes of therapeutic failure after treatment of trichomonal vaginitis with metronidazole: comparison of single-dose treatment with a standard regimen. Br. J. Clin. Pract. 28:134-136.
295. Van Andel, R. A., L. V. Kendall, C. L. Franklin, L. K. Riley, C. L. Besch-Williford, and R. R. J. Hook. 1996. Sustained estrogenization is insufficient to support long-term experimentally induced genital Trichomonas vaginalis infection on BALB/c mice. Lab. Anim. Sci. 46:689-690.
296. Videau, D., G. Niel, A. Siboulet, and F. Catalan. 1978. Secnidazole. A 5-nitroimidazole derivative with a long half-life. Br. J. Vener. Dis. 54:77-80.
297. Wang, A., C. Wang, and J. F. Alderete. 1987. Trichomonas vaginalis phenotypic variation occurs only among trichomonads with the double-stranded RNA virus. J. Exp. Med. 166:142-150.
298. Wang, A. L., and C. C. Wang. 1991. Viruses of the protozoa. Annu. Rev. Microbiol. 45:251-263.
299. Wang, C. C., and H. Cheng. 1984. Salvage of pyrimidine nucleosides by Trichomonas vaginalis. Mol. Biochem. Parasitol. 10:171-184.
300. Warton, A., and B. M. Honigberg. 1979. Structure of trichomonads as revealed by scanning electron microscopy. J. Protozool. 26:56-62.
301. Warton, A., and B. M. Honigberg. 1980. Lectin analysis of surface saccharides in two Trichomonas vaginalis strains differing in pathogenicity. J. Protozool. 27:410-419.
302. Warton, A., and B. M. Honigberg. 1983. Analysis of surface saccharides in Trichomonas vaginalis strains with various pathogenicity levels by fluorescein-conjugated plant lectins. Z. Parasitenkd. 69:149-159.
303. Watt, L., and R. F. Jennison. 1960. Incidence of Trichomonas vaginalis in marital partners. Br. J. Vener. Dis. 36:163-166.
304. Wellerson, R., and A. B. Kupferberg. 1962. On glycolysis in Trichomonas vaginalis. J. Protozool. 9:418-424.
305. Whatley, F. R. 1981. The establishment of mitochondria: Paracoccus and Rhodopseudomonas. Ann. N. Y. Acad. Sci. 361:330-340.
306. Whittington, M. J. 1957. Epidemiology of infections with Trichomonas vaginalis in the light of improved diagnostic methods. Br. J. Vener. Dis. 33:80-91.
307. Wilmott, F., J. Say, and A. Hookam. 1983. Zinc and recalcitrant trichomoniasis. Lancet i:1053.
308. Wilson, A., and J. P. Ackers. 1980. Urine culture for the detection of Trichomonas vaginalis in men. Br. J. Vener. Dis. 56:46-48.
309. Wisdom, A. R., and E. M. C. Dunlop. 1965. Trichomoniasis: study of the disease and its treatment in women and men. Br. J. Vener. Dis. 41:90-96.
310. Wolner-Hanssen, P., J. N. Krieger, C. E. Stevens, N. B. Kiviat, L. Koutsky, T. DeRouen, S. Hillier, and K. K. Holmes. 1989. Clinical manifestations of vaginal trichomoniasis. JAMA 261:571-576.
311. World Health Organization. 1995. An overview of selected curable sexually transmitted diseases, p. 2-27. In Global program on AIDS. World Health Organization, Geneva, Switzerland.
312. Wos, S. M., and R. M. Watt. 1986. Immunoglobulin isotypes of anti-Trichomonas vaginalis antibodies in patients with vaginal trichomoniasis. J. Clin. Microbiol. 24:790-795.
313. Yano, A., K. Yui, F. Aosai, S. Kojima, T. Kawana, and Z. Ovary. 1983. Immune response to Trichomonas vaginalis. IV. Immunochemical and immunobiological analyses of T. vaginalis antigen. Int. Arch. Allergy Appl. Immunol. 72:150-157.
314. Yoon, K., J. S. Ryu, and D. Y. Min. 1991. Cytotoxicity of lymphokine activated peritoneal macrophages against Trichomonas vaginalis. Kor. J. Parasitol. 29:381-388. (In Korean.)
315. Zhang, Z.-F., and C. B. Begg. 1994. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol. 23:682-690.
316. Ziomko, I., and E. Kuczynska. 1994. Trichomonacidal activity of newly synthesized derivatives of benzoizothiazolinon (BIT) in vitro. Wiad. Parazytol. 40:59-64. (In Polish.)